1. Home
  2. NGNE vs ASC Comparison

NGNE vs ASC Comparison

Compare NGNE & ASC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$23.57

Market Cap

744.9M

Sector

Health Care

ML Signal

HOLD

Logo Ardmore Shipping Corporation

ASC

Ardmore Shipping Corporation

SELL

Current Price

$19.05

Market Cap

751.7M

ML Signal

SELL

Company Overview

Basic Information
Metric
NGNE
ASC
Founded
2003
2010
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
744.9M
751.7M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
NGNE
ASC
Price
$23.57
$19.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
2
Target Price
★ $77.88
$22.50
AVG Volume (30 Days)
354.4K
★ 643.7K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
★ 1.63%
EPS Growth
★ 0.93
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$16.60
Revenue Growth
N/A
★ N/A
52 Week Low
$15.93
$10.31
52 Week High
$43.66
$20.60

Technical Indicators

Market Signals
Indicator
NGNE
ASC
Relative Strength Index (RSI) 33.88 52.63
Support Level $16.88 $18.25
Resistance Level $29.16 $19.14
Average True Range (ATR) 1.99 0.72
MACD -0.13 -0.01
Stochastic Oscillator 29.31 40.77

Price Performance

Historical Comparison
NGNE
ASC

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About ASC Ardmore Shipping Corporation

Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.

Share on Social Networks: